Position in GRFS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,601,178
-$144,386 QoQ
Shares Held
508,641
+8.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,826,194,566 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,175,866 | $1,410,369,073 | |
| 2 | JNJ |
Johnson & Johnson
|
4,910,996 | $1,247,245,654 | |
| 3 | ABBV |
AbbVie Inc.
|
4,886,670 | $1,229,681,638 | |
| 4 | AMGN |
Amgen Inc
|
1,689,843 | $611,925,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,996,890 | $513,600,365 | |
| 6 | AZN |
Astrazeneca PLC
|
2,281,431 | $432,604,946 | |
| 7 | NVS |
Novartis AG
|
2,330,979 | $365,311,028 | |
| 8 | PFE |
Pfizer Inc
|
9,513,242 | $229,078,867 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,601,178 | 508,641 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,745,564 | 467,028 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,240,756 | 346,605 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,137,895 | 515,853 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,587,175 | 286,192 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,953,067 | 274,693 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,899,030 | 255,246 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,275,189 | 256,215 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,432,559 | 227,030 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,592,097 | 238,338 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,752,366 | 238,094 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,886,075 | 206,354 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $821,285 | 89,660 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,199,430 | 162,745 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $369,767 | 43,502 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $305,677 | 49,623 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,837,515 | 154,673 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,514,779 | 129,690 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,090,893 | 97,141 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,115,454 | 144,795 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $3,012,636 | 173,639 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $11,616,459 | 671,860 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $13,145,027 | 712,854 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $13,154,717 | 758,197 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $16,332,734 | 895,435 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $17,497,531 | 868,795 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||